Shenzhen Geno-immune Medical Institute

This study tests a custom-made vaccine for people with two serious brain cancers: glioblastoma (GBM) and diffuse intrinsic pontine glioma (DIPG). The vaccine is made from the patient's own immune cells and designed to teach the body to attack the tumor. The main goals are to chec…

This early-phase trial tests a personalized cell therapy for advanced ovarian cancer. About 20 women will receive immune cells engineered to recognize and attack their cancer. The main goals are to check safety and see if the treatment shrinks tumors.

This early-stage study tests whether specially grown fetal stem cells can safely control severe symptoms of immune-related disorders and tissue damage. About 100 people with no other treatment options will receive an infusion of these cells. The main goal is to check for side eff…

This early-stage trial tests a personalized treatment for glioblastoma, an aggressive brain cancer. It uses a patient's own immune cells, modified to better recognize and attack the tumor, combined with chemotherapy. The main goal is to check safety in 30 patients with recurrent …